Try our Advanced Search for more refined results
Corporate
-
February 12, 2026
Maxeon Dodges Investor Suit Over Financial Disclosures
Maxeon Solar Technologies has escaped a shareholder class action accusing it of misleading investors about its liquidity issues, with a California federal judge ruling that none of the challenged statements in the suit were shown to be false or misleading.
-
February 12, 2026
E-Commerce Co. Opensend Sued For Docs On Insider Moves
A stockholder and director of e-commerce support venture Opensend Inc. has sued the business for books and records in Delaware's Court of Chancery, citing concerns about alleged subverting of financial controls, hiring of the company CEO's wife and business dealings with the CEO's brother.
-
February 12, 2026
2nd Circ. Seems Wary Of Restarting Norfolk Derailment Suit
The Second Circuit appeared skeptical Thursday of investors' bid to revive a proposed class action against Norfolk Southern alleging that the company botched disclosures about how an efficiency plan might cause derailments, as judges seemed open to a lower court's interpretation that railroad statements about safety were puffery.
-
February 12, 2026
Foley & Lardner Adds Gray Reed Construction Pro In Dallas
Foley & Lardner LLP has boosted the manufacturing sector of its construction practice group with a Dallas-based partner who came from Gray Reed & McGraw LLP.
-
February 12, 2026
Investment Co. Sues In Del. Over $3.5M Manhattan Condo Deal
A New York investment firm has sued the developers of a luxury Manhattan condominium tower in the Delaware Chancery Court, seeking either title to a unit in the building or more than $3.5 million in principal and returns that the investor says it is owed under a pair of agreements.
-
February 11, 2026
AbbVie Sues Medicaid, HHS Over Botox Fair Price Controls
AbbVie Inc. on Wednesday asked a D.C. federal court to block the Centers for Medicare and Medicaid Services from controlling the price of Botox under the Inflation Reduction Act, arguing the cosmetic drug and migraine treatment should be excluded from the controls because it's a "plasma-derived" product.
-
February 11, 2026
7th Circ. May Seek Ill. Justices' Input In Hyundai BIPA Row
A Seventh Circuit panel on Wednesday appeared skeptical about whether Hyundai Motor America had any control over biometric data captured by cameras installed in certain Hyundai vehicles and how a proposed class of drivers was injured under Illinois' biometric privacy law, but one judge suggested the case presents a question the state's top court may need to answer.
-
February 11, 2026
'The Shoe Is On The Other Foot': Judge Needles Meta In MDL
A California federal judge presiding over social media addiction multidistrict litigation Wednesday criticized Meta's bid to push newly filed arbitration demands into court, saying she doesn't have jurisdiction over those claims and noting "big companies" are always insisting on arbitration, but "when they don't like the fact that they're arbitrating, they complain about it."
-
February 11, 2026
AGs Warn Cos. Plastic Initiatives May Break Competition Laws
The attorneys general of 10 red states have warned 80 corporations that their purported involvement in organizations aiming to reduce plastic waste might run afoul of antitrust and consumer protection laws, following similar competition-focused actions targeting environmental and diversity groups at the state and federal levels.
-
February 11, 2026
Mobile Home Orgs Can't Bring Class Suit, Fla. Panel Says
A Florida panel ruled in a Wednesday split decision that two mobile homeowners' associations can't combine to bring one class action alleging unreasonable rent increases, citing state court rules that allow only one association to bring claims on behalf of its own members.
-
February 11, 2026
Pfizer, SEC Reach $29M Deal In Insider Trading Fund Dispute
Pfizer and the U.S. Securities and Exchange Commission have jointly asked a New York federal judge to allow $29 million out of the roughly $75.2 million distribution leftover from a $602 million insider trading deal to be paid out to a Pfizer subsidiary.
-
February 11, 2026
Blockbuster's TM Legacy Tested By Dispute Over Deer Feed
Once a titan in U.S. retail, the Blockbuster brand is embroiled in an unexpected trademark battle with a Mississippi-based animal feed company that it accuses of trying to exploit the legacy of the once-ubiquitous video rental chain.
-
February 11, 2026
CEO Criticizes 'Crazy Lawyers' In $5M Financial Adviser Feud
The chief executive officer of Prime Capital Investment Advisors LLC on Wednesday testified that he emailed a rival CEO during litigation to warn him that "crazy lawyers" could be burning millions of dollars to fight an unfair trade practices case Prime believed involved business worth $50,000 to $100,000.
-
February 11, 2026
Disney To Pay $2.75M In Record Deal Under Calif. Privacy Law
California's attorney general announced Wednesday that his office has secured its largest deal yet under the state's data privacy law, with entertainment giant Disney agreeing to pay $2.75 million and overhaul its opt-out mechanisms to resolve claims that it failed to allow consumers to completely stop the sale and sharing of their personal data.
-
February 11, 2026
Del. Justices Grapple Over Truth Social Share Math
An attorney for the firm that helped launch Donald Trump's social media company told Delaware's justices Wednesday that a vice chancellor erred in requiring the venture to "prove a negative" in calculations of investor stakes in the run-up to the venture's special purpose acquisition company transaction.
-
February 11, 2026
Estee Lauder Hits Walmart With TM Suit Alleging Copycats
Estee Lauder hit Walmart with a trademark infringement suit in California federal court Monday, accusing it of hawking copycat versions of its luxury personal care products, cosmetics and fragrance collections sold under popular brands including Clinique, La Mer and Tom Ford.
-
February 11, 2026
House OKs Ending Canada Tariffs After GOP Block Fails
The U.S. House of Representatives approved a resolution Wednesday evening that would end President Donald Trump's tariffs on Canadian imports, a day after Republican lawmakers were unable to pass a measure blocking that kind of effort.
-
February 11, 2026
Miami World Cup Counsel Share Look At Prep Work, Impact
Counsel representing the FIFA World Cup's Miami Host Committee gave Law360 an inside look at their multifaceted work preparing for the upcoming event, which organizers say could have the economic impact of multiple Super Bowls.
-
February 11, 2026
Boeing Aims To Nix Polish Airline's $8.4M Damages Report
Boeing has asked a Seattle federal judge to exclude an $8.4 million "eleventh hour" damages report prepared by a Polish airline's expert, arguing it is not only untimely but also irrelevant to testimony the jury will hear.
-
February 11, 2026
MrBeast, Ex-IT Worker Near Deal In Trade Secret Theft Dispute
YouTube star MrBeast's media company has told a North Carolina federal judge it has reached a settlement in principle to resolve its lawsuit accusing a former IT contractor of downloading thousands of confidential company documents ahead of his firing and leaving behind hidden cameras throughout the company's offices.
-
February 11, 2026
Egypt's 'Social Law' Doesn't Endorse Bribery, Jury Told
Attorneys for a former Corsa Coal executive on trial for allegedly passing bribes sought to undermine an expert witness's opinions that bribery was illegal in Egypt, confronting him with law review articles he'd written that said corruption was commonly accepted and had become the "social law."
-
February 11, 2026
Pegasystems Settles Mass. Shareholder Actions For $7M
Pegasystems has agreed to pay $7 million to settle three shareholder derivative suits in Massachusetts state and federal courts alleging the software company's top officials sat on details of a 2020 trade secrets suit that led to a now-overturned $2 billion verdict.
-
February 11, 2026
Beasley Allen Wants Talc DQ Paused Pending High Court Appeal
Hundreds of women who claim their ovarian cancer was caused by Johnson & Johnson's talcum powder risk appearing in an upcoming trial without their preferred counsel from the Beasley Allen Law Firm, unless a New Jersey state court stays an order disqualifying the firm, it said.
-
February 11, 2026
Stockholder Sues AI Firm Airship In Del. For Books, Records
A California stockholder of a California-based artificial intelligence communication company has filed suit in the Delaware Chancery Court seeking to force the agency to turn over financial and board records, alleging that it has improperly limited his access to information needed to value his shares.
-
February 11, 2026
Paul Hastings Adds Ex-Norton Rose Investment Funds Pro
Paul Hastings LLP has added an investment funds specialist who previously worked with Norton Rose Fulbright as a partner in its Chicago office, the firm announced Wednesday.
Expert Analysis
-
What US Can Learn From Brazil's Securities Arbitration Model
To allay investor concerns about its recent approval of mandatory arbitration clauses in public company registration statements, the U.S. Securities and Exchange Commission should look to Brazil's securities arbitration model, which shows that clear rules and strong institutions can complement the goals of securities regulation, say arbiters at the B3 Arbitration Chamber.
-
Navigating The New Patchwork Of Foreign-Influence Laws
On top of existing federal regulations, an expanding wave of state legislation — placing new limits on foreign-funded political spending and new registration requirements for foreign agents — creates a confusing compliance backdrop for corporations that demands careful preplanning, say attorneys at BakerHostetler.
-
AI Evidence Rule Tweaks Encourage Judicial Guardrails
Recent additions to a committee note on proposed Rule of Evidence 707 — governing evidence generated by artificial intelligence — seek to mitigate potential dangers that may arise once machine outputs are introduced at trial, encouraging judges to perform critical gatekeeping functions, say attorneys at Lankler Siffert & Wohl.
-
Terrorist Label For Maduro Poses New Risks For US Firms
The State Department's recent designation of President Nicolás Maduro, and other Venezuelan government and military officials, as members of a foreign terrorist organization drastically increases the level of caution companies must exercise when doing business in the region to mitigate potential civil, criminal and regulatory risk, say attorneys at Freshfields.
-
Series
The Law Firm Merger Diaries: Getting The Message Across
Communications and brand strategy during a law firm merger represent a crucial thread that runs through every stage of a combination and should include clear messaging, leverage modern marketing tools and embrace the chance to evolve, says Ashley Horne at Womble Bond.
-
2 Early Settlement Alternatives In Federal Securities Litigation
Most class actions brought under the federal securities laws are either settled or won by the defendants following a motion to dismiss, but two alternative strategies have the potential to lower discovery costs and allow defendants to obtain judgment without the uncertainty of jury trials on complex matters, says Richard Zelichov at DLA Piper.
-
Opinion
Horizontal Stare Decisis Should Not Be Casually Discarded
Eliminating the so-called law of the circuit doctrine — as recently proposed by a Fifth Circuit judge, echoing Justice Neil Gorsuch’s concurrence in Loper Bright — would undermine public confidence in the judiciary’s independence and create costly uncertainty for litigants, says Lawrence Bluestone at Genova Burns.
-
How Fed. Circ. Shaped Subject Matter Eligibility In 2025
The Federal Circuit's most impactful patent eligibility decisions this year, touching on questions about obviousness and abstractness, provide a toolbox of takeaways that can be utilized during patent preparation and prosecution to guard against potential challenges, says Reilley Keane at Banner Witcoff.
-
DC Circ. Decision Reaffirms SEC Authority Post-Loper Bright
The recent denial of a challenge to invalidate 2024 amendments to the U.S. Securities and Exchange Commission's tick size and fee-cap rules reinforces the D.C. Circuit's deference to SEC expertise in market structure regulation, even after Loper Bright, though implementation of the rules remains uncertain, say attorneys at Sidley.
-
10 Commandments For Agentic AI Tools In The Legal Industry
Though agentic artificial intelligence has demonstrated significant promise for optimizing legal work, it presents numerous risks, so specific ethical obligations should be built into the knowledge base of every agentic AI tool used in the legal industry, says Steven Cordero at Akerman LLP.
-
NY Tax Talk: New ALJs, New Rules, Apportionment, Bundling
Attorneys at Eversheds review the top New York tax law developments from last quarter, including appointments to the New York City Tax Appeals Tribunal and the city's proposed rules to clarify income taxation of foreign corporations, and highlight two litigation matters to watch.
-
Series
Preaching Makes Me A Better Lawyer
Becoming a Gospel preacher has enhanced my success as a trial lawyer by teaching me the importance of credibility, relatability, persuasiveness and thorough preparation for my congregants, the same skills needed with judges and juries in the courtroom, says Reginald Harris at Stinson.
-
Why Digital Asset Treasuries Are Drawing Regulator Concerns
Financial regulators’ recent focus on potential insider trading and investor risk at hundreds of publicly traded digital asset treasuries may have been summoned by how quickly this rapidly expanding market responds to asset allocation decisions, as well as variations in risk disclosure practices across the sector, say attorneys at The Brattle Group.
-
FTC Focus: Amazon's $2.5B Pact Broadens Regulatory Span
Amazon's $2.5 billion deal with the Federal Trade Commission offers takeaways for counsel managing risk across both consumer protection and competition portfolios, including that design strategies once evaluated solely for conversion may now be scrutinized for their competitive effects, say attorneys at Proskauer.
-
SEC Penalties Trended Down In FY 2025, Offering 2026 Clues
The U.S. Securities and Exchange Commission's settled corporate penalties in fiscal year 2025 show a clear dividing line, as the largest penalties all came before Inauguration Day, a trend that may continue as the types of cases that lead to the biggest penalties seem to be no longer favored by the commissioners, say attorneys at Dentons.